Marc Beer

Marc Beer: The Importance of Illumination

During any surgical procedure, adequate illumination is the most important factor. Even the most experienced surgeon with the most skilled hands can cause irreparable damage to their patient and their career. For years, no one product has held the title of “most preferred by surgeons” when it comes to lighting.

One product most people think of when they think about illumination during surgeries is what they see in movies and on TV; one big light hanging over the operating table. While surgeons and doctors alike have used electric bulbs for many years, they never really liked to use them. Those giant electric bulbs were extremely bulky, they burned hot quickly and burned out, they offered poor illumination, and they consumed way too much energy.

Recently, LumeNXT, Inc. announced a new line of products that made the company’s new Chairman of the Board, Marc Beer, excited to be a part of the company. LumeNXT created a product line that combined white light-emitting diodes, micro-electronic switching technology, and compacted high-power batteries. Its new product line features small high-intensity non-tethered lighting sources.

That may all sound technical and boring, but to put in laymen’s terms, the company’s new lights will allow doctors and surgeons to place precision lighting into or on the edge of the surgical site. The notion of lighting from within has the entire medical industry up in a roar but in a good way. Everyone is excited to start working with an illumination source that can improve surgery safety and quickness.

These little lights are latex-free and come individually wrapped for convenience. They can only be used one time, but they required approximately one-twentieth of the energy required by the standard large electric bulbs, and they produce better lighting. They’re small enough to fit into a cavity, they produce no heat, and they’re inexpensive.

Marc Beer made a great choice for a new Chairman of the Board because he’s used to looking for and bringing new medical solutions to the field. One of his first companies was Renovia, Inc., a company dedicated to creating therapeutic and diagnostic devices for women suffering from pelvic floor disorder.

Though Renovia made Marc Beer an industry-known name, he also founded Minerva Neurosciences Inc., a company that looked for medicines that would help people suffering from schizophrenia, insomnia, and other mood disorders, including depressive disorders and Parkinson’s disease. Learn more: http://inspirery.com/interview-with-marc-beer/

Marc Beer Views on Technology and Leadership in Health Care

The medical world, especially medical investment is a unique niche in different ways. For example, the niche requires professionals that are not only inspired to solve human problems but also passionate for creating sustainable remedies for people around the globe. Marc Beer is a problem solver in this niche, and over the years, he has illustrated the importance of being inspired and passionate in the world of medical investment. In an interview with a popular medical journal, Beer also confessed that his two and a half decades in this niche has been a season for learning and more critically, a season for learning about his abilities and passions. 

 

Renovia — his latest outfit in his long and successful career — represents his passion for humanity and more specifically for women. He is a believer that women deserve more than what conventional medicine offers. Marc Beer — through a series of interactions with other industry players — has realized that there is a huge gap between the conventional medical options and the complications women have, as far as reproductive health is concerned. Through this start-up, he hopes to bring the best technology in creating different medical alternatives to medical professionals dealing with women reproductive health around the world. Learn more: https://www.crunchbase.com/person/marc-beer

 

In his long journey in creating solutions for women reproductive health, he has mastered the art of involving other industry players. Marc Beer understands that there is a need for more resources in this niche, and therefore, working with different investors and researchers is vital. Beer has a two-part criterion when bringing other people to his projects. First, the professional selected must have a similar view on reproductive health, and the similarity in opinions is a vital feature in the success of any project. Second, any potential entity must fit in his company’s description of a partner, where the value of life is irreplaceable.

 

Marc Beer is, however, more synonymous with his contributions to medical research and more importantly, research that involves women health. In Renovia, for example, he has taken his time to bring the best talents in research, especially on alternative medicine. He points out that research is what has revolutionized the medical world in the last 200 years, and it will be the main propeller to the next phase of medicine. In the past 36 months, he has invested his time in looking for the best researchers on different niches — and therefore making his company home to some of the best talents in this niche.

 

Lastly, he appreciates futuristic management, and as a founder to a medical start-up, he has brought the best administrators to his company. Marc Beer understands that although he has the best research minds in the world of alternative medicine, the company’s logistics determine the success of his company. 

Marc Beer

Marc Beer is the recently appointed new chairman of the board at LumeNXT, Inc. This company recognizes Beer’s significant impact on the health industry. He has successfully started up many companies, offering leadership and guidance that gives significant growth results to those specific corporations. He is an experienced and reputed biotechnologist with 25 years of experience in developing and commercializing pharmaceutical and biotechnology devices.

 

Additionally, Beer is the co-founder of Renovia, Inc, a company that enhances restorative and test procedures for women with pelvic-related issues. Situated in the state of Massachusetts, the company’s success is related to its formulation of digital devices for both diagnosis and treatment.

 

He also attributes to the significant contributions of societal well-being. He presently funded the women’s health startup at Renovia, Inc. through the raising of $42M. This company created diagnostic devices for pelvic floor disorders in women, and also therapeutic mechanisms for treating and relieving such-like ailments. The raised funds directed at the development and assessment of other four new products.

 

The co-founder of LumeNXT, Paul Rhyne, says that they are confident of Beer’s excellent contribution towards LumeNXT growth and betterment. He further states that Beer’s significant contributions to the global commercial initiations and further successes are sources of hope for the bright anticipated future of LumeNXT.

 

LumeNXT, Inc. is a private co-owned company that focuses on developing advanced surgical illumination products. Their focus is primarily on minimally invasive surgery. Beer is proud to join the LumeNXT group. He says that he is happy and anticipates working with the great team at LumeNXT. He further describes the group of workers at his newly-joined company as devoted, exceptional, and well-advanced in the surgical illumination sector.

 

Previously, Beer served as the CEO founder of ViaCell, which he joined in April 2000. This biotechnology company collects preserves and develops umbilical cord blood stem cells. Marc Beer’s leadership at ViaCell expanded the company to over 300 employees. It also received high publicity in 2005, before its ultimate acquisition by PerkinElmer in 2007.

 

Before, Beer served top positions at Genzyme, He had worked in different firms where he sharpened his skills and gained invaluable experiences. He was also the vice president at Global Marketing. His principal responsibility at Global Marketing was the launching and commercializing of a line of products which addresses rare illnesses amongst populations and at a global extent.

 

Beer, who was also the chairman of the compensation committee of Good Start Genetics, Inc. says that the minimally invasive surgery adopted by LumeNXT is a safe procedure due to its better visualization. Furthermore, he adds that people are yet to realize the significance of LumeNXT, and especially with the increase of more surgeries that will happen using the minimally invasive technology. Learn more: https://renoviainc.com/leadership/

 

Marc Beer Named New Chairman at LumeN XT

LumeN XT is a leading healthcare company that has recently made a new addition to its management team. The company recently named Marc Beer to serve as the new Chairman. With the naming of Marc Beer, LumeN XT will be adding one of the most successful executives in the healthcare industry. He brings 25 years of experience to the healthcare industry. Beer has spent much of his career developing and commercializing for biotechnology companies, pharmaceutical companies, medical devices and diagnostics. In his new leadership role at LumeN XT, Marc will help the company continue to reach its goals in advancing medical technology.

 

Once he was named as the new Chairman at LumeN XT, Marc Beer made a statement. In a recent discussion, Beer revealed that he is very happy to be working with renowned engineers and surgeons who are dedicated to advancing surgical illumination technology. Marc also said that the surgical illumination technology is very important to making surgery safer and should therefore be a priority in providing future medical treatment. Beer has said that LumeN XT will increase as more surgeries are performed in a less invasive manner.

 

Surgeons that have used illumination have found out that this technology provides a number of benefits. These include enhanced vision, more precision and increased flexibility during operations. Compared to other techniques, surgical illumination has proven to be more superior. LumeN XT currently offers an advanced illumination platform that includes a heat reduction mechanism. This improves the precision of surgical procedures along with providing low cost disposable options and safety with improved vision.

 

The founder of LumeN XT Paul Rhyne made a statement himself about the recent addition of Marc Beer. Rhyne revealed that Marc demonstrated a high level of success in terms of managing startup companies. Over the course of his career, Marc has helped the companies experience important phases of growth. Rhyme also said that the vast amount of experience of Marc has resulted in guiding startup companies in terms of global expansion and increased profitability. Learn more: https://renoviainc.com/leadership/

 

Marc Beer founded and serves as the top executive of Renovia Inc. Beer founded this company with a mission to provide solutions for women suffering from pelvic floor disorders. His company developed medical devices that provide therapy and diagnostics. During the past few years, Renovia has emerged as a leading medical technology company. Before he founded Renovia, Marc Beer was the Founding Chairman of Minerva Neurosciences. This company was a biopharmaceutical company that looked to treat a number of diseases of the central nervous system. This company conducted clinical trials as well as develop effective therapy options for conditions such as Parkinson’s Disease, insomnia, schizophrenia and depression. His success with these two companies has helped Marc establish lots of credibility as an entrepreneur and executive in the healthcare industry.

 

The Co-Founder, Chairman, and CEO at Renovia Inc., Marc Beer Raises Funds to Support Development of Women Pelvic Floor Treatment Products

Recently, Marc Beer, the Co-Founder of Renovia Inc. raised $42 million to fund women`s health startup at Renovia Center. Renovia Inc. is a Boston based health company that develops diagnostic and therapeutic devices for treating various pelvic floor disorders. The company was founded in August 2016, and the founding members were Ramon Iglesias, Marc Beer, and Yolanda Lorie and in the same year, they successfully closed Series A financing venturing with leading healthcare capital fund. Marc Beer has over 25 years of experience operating in the development and commercialization sectors.

 

Before Co-Founding Renovia Inc., Marc has established several other firms. In April 2000, Marc became the founding Chief Executive Officer of ViaCell. Under his management, the company increased to a robust commercial organization. ViaCell is a biotechnology company with a specialty in the collection, preservation, and development of umbilical cord stem cells.

 

Marc Beer closed Series B financing in two cycles, first one worth $32 million and second cycle worth $10 million in venture debt. The funding will be used in developing and testing four more therapeutic and diagnostic products as well as improving the new advanced Leva devices. Leva products were the first Renovia`s products, and in April they were approved by FDA. It is estimated that about 200 million women in the world suffer from pelvic floor disorders which includes urinary incontinence.

 

Series B financing round was led by advisors from New York and Missouri based Ascension Ventures. Longwood Fund, a healthcare investment group which previously had invested in Renovia also took part in Series B. On behalf of the company; Marc Beer appreciated the support received from leading healthcare investors who generously shares the company`s vision of helping women worldwide diagnose, treat and improve their lives. He added that through working together and combining innovative skills and proprietary sensor technologies as well as forming baseline factors with digital platform clients would receive the necessary information regarding pelvic disorders and also services will be offered at a relatively low price compared to other medical centers across the world.

 

Renovia Inc. management team are dedicated and values clients’ health as their priority. Marc Beer is the CEO although he operates with the help of other officials. Some of the top officials overseeing the smooth progress of Renovia include:

  1. William Dull, the Chief Commercial Officer. His major role is to oversee global commercial and company`s operation.
  2. Dr. Samantha Pulliam, MD who is the Chief Medical Officer. Previously she worked as Assistant professor of Obstetrics and Gynecology at the University of North Carolina.
  3. Jessica McKinney, PT, MS, CMPT. She is the Vice President of Medical Affairs and Clinical Advocacy.

Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html